Abstract
Background and Purpose: Transgender people often experience suboptimal contraception counseling due to clinicians’ insufficient experience in this topic, and practitioners themselves report lack of satisfactory training. We aim to summarize the current literature on contraception counselling in transgender men and nonbinary people assigned female at birth.
Methods: The present article is a narrative review. Searches were performed in Pubmed and Google Scholar databases using the terms ‘transgender’, ‘transmen’, ‘contraception’, ‘family planning’, ‘reproductive care’. Only English and Portuguese written articles published in the last six years were considered. A manual search of references from identified studies was also conducted and international guidelines were searched for information of interest.
Results: Existing literature suggests that transgender men and nonbinary people assigned female at birth experience significant barriers to health services that can compromise their reproductive health. Regarding contraceptive options, all methods can be offered, according to the same eligibility criteria used for cisgender women. Nevertheless, specificities must be considered: differential acceptance of side effects, potential emotional and physical discomfort inherent to pelvic examination. Both patients and their healthcare providers may be unaware of the fact that ovulation may occur during testosterone treatment, even if the person is in amenorrhea. Hence, it should not be considered for effective contraception. Also, it has known teratogenic effects, which highlights the need for preventing unplanned pregnancies. Until date, there is no evidence that testosterone use is a contraindication to any contraceptive method, therefore, transmen on this medication should be offered all options.
Conclusions: All contraceptive methods can be offered to transgender men and nonbinary individuals assigned female at birth, but the specific needs and concerns of these individuals should be considered in counseling. Literature on this field is still scarce and more studies are needed to evaluate preferences and satisfaction rates.
References
T’Sjoen G, Arcelus J, De Vries ALC, et al. European Society for Sexual Medicine Position Statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction”. J Sex Med. 2020;17(4):570–584.
Brandt J, Patel A, Marshall I, Bachmann GA. Transgender men, pregnancy, and the “new” advanced paternal age: A review of the literature. Maturitas. 2019;128:17–21.
Coleman E, Radix AE, Bouman WP, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022;23(Suppl 1):S1-S259.
Growing recognition of transgender health. Bull World Health Organ. 2016 Nov 1;94(11):790-791.
Krempasky C, Harris M, Abern L, Grimstad F. Contraception across the transmasculine spectrum. Am J Obstet Gynecol.2020;222(2):134-143.
Stark B, Hughto JMW, Charlton BM, Deutsch MB, Potter J, Reisner SL. The contraceptive and reproductive history and planning goals of trans-masculine adults: a mixed-methods study. Contraception. 2019;100(6):468–473.
Mancini I, Alvisil S, Gava G, Seracchioli R, Meriggiola MC. Contraception across transgender. Int J Impot Res. 2020;33(7):710-719.
Okano SHP, Pellicciotta GGM, Braga GC. Contraceptive Counseling for the Transgender Patient Assigned Female at Birth. Rev Bras Ginecol Obstet. 2022;44(9):884-890.
Trans Population by Country / Transgender Population by Country 2024. Accessed February 25, 2024. https://worldpopulationreview.com/country-rankings/trans-population-by-country
Agénor M, Murchison R, Najarro J, et al. Mapping the scientific literature on reproductive health among transgender and gender diverse people: a scoping review. Sex Reprod Health Matters. 2021;29(1):1886395.
Bonnington A, Dianat S, Kerns J, et al. Society of Family Planning clinical recommendations: Contraceptive counseling for transgender and gender diverse people who were female sex assigned at birth. Contraception. 2020;102(2):70–82.
Rodriguez A, Agardh A, Asamoah B. Self-Reported Discrimination in Health-Care Settings Based on Recognizability as Transgender: A Cross-Sectional Study Among Transgender U.S. Citizens. Arch Sex Behav. 2018;47(4):973–985.
Kasten Z, Lujan S, Jakeman B, et al. Contraceptive use in patients with gender dysphoria who were assigned female at birth receiving care at a specialty gender affirming clinic. J Am Pharm Assoc (2003). 2024;64(1):273-277.
ACOG Committee Opinion No. 823, Health Care for Transgender and Gender Diverse Individuals: Correction. Obstet Gynecol. 2022;139(2):345.
Pulice-Farrow L, Gonzalez KA, Lindley L. ‘None of my providers have the slightest clue what to do with me’: Transmasculine individuals’ experiences with gynecological healthcare providers. Int J Transgend Health. 2020;22(4):381-393.
Klein DA, Berry-Bibee EN, Keglovitz Baker K, Malcolm NM, Rollison JM, Frederiksen BN. Providing quality family planning services to LGBTQIA individuals: a systematic review. Contraception. 2018;97(5):378-391.
Lowik AJ. “Just because I don’t bleed, doesn’t mean I don’t go through it”: Expanding knowledge on trans and non-binary menstruators. Int J Transgend Health. 2021;22(1-2):113-125.
Faculty of Sexual and Reproductive Health. FSRH CEU Clinical Statement: Contraceptive Choices and Sexual Health for Transgender and Non-Binary People. London: FSRH; 2017.
Kanj RV, Conard LAE, Corathers SD, Trotman GE.. Hormonal contraceptive choices in a clinic-based series of transgender adolescents and young adults. Int J Transgend. 2019;20(4):413–420.
Schwartz AR, Russell K, Gray BA. Approaches to vaginal bleeding and contraceptive counseling in transgender and gender nonbinary patients. Obstet Gynecol. 2019;134(1):81–90.
Light A, Wang L, Zeymo A, Gomez-Lobo V.. Family planning and contraception use in transgender men. 2018;98(4):266-269.
Paradise S, Landis C, Klein D. Evidence-Based Contraception: Common Questions and Answers. Am Fam Physician. 2022;106(3):251-259.
Cipres D, Seidman D, Cloniger C 3rd, Nova C, O’Shea A, Obedin-Maliver J. Contraceptive use and pregnancy intentions among transgender men presenting to a clinic for sex workers and their families in San Francisco. Contraception. 2017;95(2):186–189.
Gomez A, Đỗ L, Ratliff G, Crego PI, Hastings J. Contraceptive Beliefs, Needs, and Care Experiences Among Transgender and Nonbinary Young Adults. J Adolesc Health. 2020;67(4):597-602.
Berglin M, Stram D, Stenquist A, Dessi S, Ritterman Weintraub M, Zaritsky E. Intrauterine device, subdermal contraceptive, and depot medroxyprogesterone use among transmasculine and cisgender patients over a 10-year period. Contraception. 2022;108:56-60.
Bentsianov S, Gordon L, Goldman A, Jacobs A, Steever J. Use of Copper Intrauterine Device in Transgender Male Adolescents. Contraception. 2018;98(1):74–75.
Taub R, Ellis S, Neal-Perry G, Magaret AS, Prager SW, Micks EA. The effect of testosterone on ovulatory function in transmasculine individuals. Am J Obstet Gynecol. 2020;223(2):229.e1-229.e8.
Boudreau D, Mukerjee R. Contraception Care for Transmasculine Individuals on Testosterone Therapy. J Midwifery Womens Health. 2019;64(4):395-402.
Mehringer J, Dowshen N. Sexual and reproductive health considerations among transgender and gender-expansive youth. Curr Probl Pediatr Adolesc Health Care. 2019;49(9):100684.
Schubert FD, Carey JM. Data unclear on pregnancy risk in transmasculine individuals on testosterone. Am J Obstet Gynecol. 2020;222(4):393-394.
Rodriguez-Wallberg K, Obedin-Maliver J, Taylor B, Van Mello N, Tilleman K, Nahata L. Reproductive health in transgender and gender diverse individuals: A narrative review to guide clinical care and international guidelines. Int J Transgend Health. 2022;24(1):7-25.
Moseson H, Fix L, Hastings J, et al. Pregnancy intentions and outcomes among transgender, nonbinary, and gender-expansive people assigned female or intersex at birth in the United States: Results from a national, quantitative survey. Int J Transgend Health. 2021;22(1-2):30-41.
Abern L, Maguire K. Contraception knowledge in transgender individuals: are we doing enough? Obstet Gynecol. 2018;131:65.
Montoya M, Peipert BJ, Whicker D, Gray B. Reproductive Considerations for the LGBTQ+ Community. Prim Care. 2021;48(2):283–297.
Nisly NL, Imborek KL, Miller ML, Kaliszewski SD, Williams RM, Krasowski MD. Unique Primary Care Needs of Transgender and Gender Non-Binary People. Clin Obstet Gynecol. 2018;61(4):674-686.
Sociedade Portuguesa de Contraceção. Consenso Sobre Contraceção. 2020.
May J. FDA Label Update Reflects Bayers’s Commitment to Providing Options for Long-acting Contraception. Published August 18, 2022. Accessed February 28, 2024. https://www.businesswire.com/news/home/20220817005818/en/FDA-Label-Update-Reflects-Bayer%E2%80%99s-Commitment-to-Providing-Options-for-Long-acting-Contraception
Lavelanet AF, Ralphb JA, Ti A, Duggaraju A, Yeh PT. A systematic review exploring the contraception values and preferences of sex workers, transmasculine individuals, people who inject drugs, and those living in humanitarian contexts. Contraception. 2022;111:32–38.
Ali M, Akin A, Bahamondes L, et al.; WHO study group on subdermal contraceptive implants for women. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant. Hum Reprod. 2016;31(11):2491-2498.
Agana MG, Greydanus DE, Indyk JA, et al. Caring for the transgender adolescent and young adult: Current concepts of an evolving process in the 21st century. Dis Mon. 2019;65(9):303-356.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Sofia Albuquerque Brás, Patrícia Isidro Amaral, Ana Isabel Machado